IRIS
DI MARTINO, MARIA TERESA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 606
EU - Europa 576
AS - Asia 354
AF - Africa 21
SA - Sud America 17
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.583
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 582
IT - Italia 359
SG - Singapore 178
GB - Regno Unito 64
IN - India 44
DE - Germania 31
CN - Cina 30
NL - Olanda 27
JO - Giordania 21
SE - Svezia 18
HK - Hong Kong 16
CA - Canada 15
PK - Pakistan 15
FI - Finlandia 11
ID - Indonesia 11
ES - Italia 10
BR - Brasile 9
FR - Francia 9
SA - Arabia Saudita 9
RU - Federazione Russa 8
EG - Egitto 7
LT - Lituania 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
IE - Irlanda 6
PT - Portogallo 6
ZA - Sudafrica 6
CZ - Repubblica Ceca 5
IR - Iran 5
MX - Messico 5
AT - Austria 4
CY - Cipro 4
BG - Bulgaria 3
ET - Etiopia 3
LB - Libano 3
NG - Nigeria 3
PE - Perù 3
CH - Svizzera 2
CO - Colombia 2
EC - Ecuador 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
KR - Corea 2
LK - Sri Lanka 2
MA - Marocco 2
MY - Malesia 2
PH - Filippine 2
PS - Palestinian Territory 2
UA - Ucraina 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
EE - Estonia 1
EU - Europa 1
IQ - Iraq 1
NZ - Nuova Zelanda 1
RO - Romania 1
VN - Vietnam 1
Totale 1.583
Salva come PNG Salva come JPEG
Città #
Singapore 117
Chandler 110
Santa Clara 43
Chicago 42
London 38
Ashburn 35
Milan 26
Lawrence 24
Princeton 24
Catanzaro 17
Rome 17
Amman 13
Naples 13
Hong Kong 12
Parma 12
San Nicola Manfredi 12
Helsinki 11
Boardman 10
Spezzano della Sila 10
Palermo 9
Wilmington 9
Delhi 8
Irbid 8
Los Angeles 8
Munich 8
Cosenza 7
Des Moines 7
Kaunas 7
Madrid 7
Ottawa 7
Catania 6
Ercolano 6
Santo Stefano di Rogliano 6
Settingiano 6
Sezze 6
Cardiff 5
Frankfurt am Main 5
Lucknow 5
Melito di Porto Salvo 5
Meppel 5
Riyadh 5
Sacramento 5
Afragola 4
Ahmedabad 4
Cape Town 4
Hanover 4
Hyderabad 4
Jeddah 4
New York 4
Nicosia 4
Oristano 4
Perugia 4
Pune 4
Redmond 4
Seattle 4
West Jordan 4
Acquaviva delle Fonti 3
Addis Ababa 3
Ajman 3
Banyumas 3
Berlin 3
Bristol 3
Castrovillari 3
Decollatura 3
Dubai 3
Dublin 3
Islamabad 3
Lima 3
Melbourne 3
Mileto 3
Olomouc 3
Oxford 3
Paola 3
Quţūr 3
Redwood City 3
Richmond 3
San Antonio 3
San Francisco 3
Santo Tirso 3
Shanghai 3
Sofia 3
Toronto 3
Waterford 3
6th of October City 2
Agrigento 2
Amsterdam 2
Asyut 2
Augusta 2
Bekasi 2
Bogotá 2
Bologna 2
Brescia 2
Buffalo 2
Campobello di Licata 2
Chennai 2
Colombo 2
Council Bluffs 2
Cropani 2
Edmonton 2
Fayetteville 2
Totale 907
Salva come PNG Salva come JPEG
Nome #
Pharmacogenetics/Pharmacogenomics of Drug-Metabolizing Enzymes and Transporters 309
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells 73
miR-22 suppresses DNA ligase III addiction in multiple myeloma 73
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 63
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review 52
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 51
Non-coding RNAs in cancer: Platforms and strategies for investigating the genomic "dark matter" 49
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 47
DMET-Analyzer: automatic analysis of Affymetrix DMET Data 46
Identifying prognostic markers for multiple myeloma through integration and analysis of MMRF-CoMMpass data 45
Raman Spectroscopic Stratification of Multiple Myeloma Patients Based on Exosome Profiling 43
Augmented reality (AR) in minimally invasive surgery (MIS) training: where are we now in Italy? The Italian Society of Endoscopic Surgery (SICE) ARMIS survey 42
A 46,XY Female with a 9p24.3p24.1 Deletion and a 8q24.11q24.3 Duplication: A Case Report and Review of the Literature. 41
A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer 38
Error-prone DNA repair pathways as determinants of immunotherapy activity: an emerging scenario for cancer treatment 38
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 36
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas 35
Allometric scaling approaches for predicting human pharmacokinetic of a locked nucleic acid oligonucleotide targeting cancer-associated miR-221 35
DmetTM genotyping: Tools for biomarkers discovery in the era of precision medicine 35
Mmrf-commpass data integration and analysis for identifying prognostic markers 34
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 33
Pharmacogenomics biomarker discovery and validation for translation in clinical practice. 32
null 31
From single level analysis to multi-omics integrative approaches: A powerful strategy towards the precision oncology 30
Chromene Derivatives as Selective TERRA G-Quadruplex RNA Binders with Antiproliferative Properties 28
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92 28
Genetic variants associated with gastrointestinal symptoms in Fabry disease. 26
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats 26
An Anti-BCMA RNA Aptamer for miRNA Intracellular Delivery 24
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes 24
A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells 24
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 23
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma 22
Ethical Perspectives on Pharmacogenomic Profiling 17
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy 17
In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells 14
From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology 14
Tools in Pharmacogenomics Biomarker Identification for Cancer Patients 14
The potential role of miRNAs in multiple myeloma therapy 12
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience 10
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 9
Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: In vitro and in vivo anti-tumor activity 8
Current status of liver surgery for non-colorectal non-neuroendocrine liver metastases: the NON.LI.MET. Italian Society for Endoscopic Surgery and New Technologies (SICE) and Association of Italian Surgeons in Europe (ACIE) collaborative international survey 7
Hit identification of novel small molecules interfering with MALAT1 triplex by a structure-based virtual screening 7
LNA-i-miR-221 activity in colorectal cancer: A reverse translational investigation 7
The EASY-NET research programme: background, structure, and methodology 6
A systematic review of non-coding RNA therapeutics in early clinical trials: a new perspective against cancer 6
TERRA G-quadruplex stabilization behind the anti-multiple myeloma activity: Novel insights about resveratrol pleiotropic effects 5
null 4
Totale 1.693
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.118
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.118
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202022 0 0 0 0 0 0 0 0 0 0 12 10
2020/202163 11 1 2 5 10 5 6 7 6 9 1 0
2021/2022126 3 0 0 22 5 0 4 21 34 15 17 5
2022/2023424 55 25 28 13 68 27 7 25 52 41 55 28
2023/2024482 92 33 42 40 45 72 25 42 10 19 27 35
2024/2025565 81 31 27 37 66 120 66 55 56 25 1 0
Totale 1.693